Steve Saviuk, president and CEO of Valeo Pharma (VPH.C), talks about the transformative partnerships with international players such as Novartis and members of the Canadian Healthcare Industry, that allow the company to bring leading innovative products to the Canadian market. Tune in!
Valeo Pharma (VPH.C) CEO Steve Saviuk talks specialty pharma opportunity (Ep4) Chris’ Corner
Latest Articles
- Alta Copper (ATCU.T): A slow-burn copper story on the cusp of ignition
- Lithium Ionic (LTH.V): Advancing project fast in Brazil’s spod-lithium belt
- Brazil Potash (GRO.NYSE) up 33% on $200m power line agreement
- Emerita Resources (EMO.V) vs. the state: A decade-long legal saga nearing its end
- Standard Uranium (STND.V) gears up Corvo project, eyes new drill targets
Top Searches
Abitibi Greenstone Belt Barrick Gold best canadian cannabis company biotech Bitcoin blockchain bullion Canada cannabis CBD China Chris Parry covid cryptocurrency DEFN.V Fraser Institute gambling Gold gold price. gold prices Greg Nolan hemp inflation interest rates investing investments lithium Lukas Kane marijuana mining money Newmont Goldcorp Nexus Gold pharmaceuticals psychedelics resources shrooms stock market stocks technology trading uranium wealth wealth creation weed
Leave a Reply